1067 related articles for article (PubMed ID: 33708109)
1. Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19.
Peter AE; Sandeep BV; Rao BG; Kalpana VL
Front Pharmacol; 2020; 11():583777. PubMed ID: 33708109
[TBL] [Abstract][Full Text] [Related]
2. Fighting the storm: could novel anti-TNFα and anti-IL-6
Kovalchuk A; Wang B; Li D; Rodriguez-Juarez R; Ilnytskyy S; Kovalchuk I; Kovalchuk O
Aging (Albany NY); 2021 Jan; 13(2):1571-1590. PubMed ID: 33465050
[TBL] [Abstract][Full Text] [Related]
3. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
[TBL] [Abstract][Full Text] [Related]
4. Calming the inflammatory storm in severe COVID-19 infections: Role of biologics- A narrative review.
Banji D; Alqahtani SS; Banji OJF; Machanchery S; Shoaib A
Saudi Pharm J; 2021 Mar; 29(3):213-222. PubMed ID: 33850422
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy.
Shibabaw T
J Inflamm Res; 2020; 13():673-680. PubMed ID: 33116747
[TBL] [Abstract][Full Text] [Related]
6. Cytokine Storm in COVID-19: Immunopathogenesis and Therapy.
Zanza C; Romenskaya T; Manetti AC; Franceschi F; La Russa R; Bertozzi G; Maiese A; Savioli G; Volonnino G; Longhitano Y
Medicina (Kaunas); 2022 Jan; 58(2):. PubMed ID: 35208467
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F; Chiovato L; Rotondi M
Front Immunol; 2021; 12():668507. PubMed ID: 33981314
[TBL] [Abstract][Full Text] [Related]
8. Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm.
Rabaan AA; Al-Ahmed SH; Muhammad J; Khan A; Sule AA; Tirupathi R; Mutair AA; Alhumaid S; Al-Omari A; Dhawan M; Tiwari R; Sharun K; Mohapatra RK; Mitra S; Bilal M; Alyami SA; Emran TB; Moni MA; Dhama K
Vaccines (Basel); 2021 Apr; 9(5):. PubMed ID: 33946736
[TBL] [Abstract][Full Text] [Related]
9. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
[TBL] [Abstract][Full Text] [Related]
10. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.
Yokota S; Miyamae T; Kuroiwa Y; Nishioka K
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33671159
[TBL] [Abstract][Full Text] [Related]
11. Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19.
Talukdar J; Bhadra B; Dattaroy T; Nagle V; Dasgupta S
Biomed Pharmacother; 2020 Dec; 132():110886. PubMed ID: 33113418
[TBL] [Abstract][Full Text] [Related]
12. Repurposing of drugs for combined treatment of COVID-19 cytokine storm using machine learning.
Gantla MR; Tsigelny IF; Kouznetsova VL
Med Drug Discov; 2023 Feb; 17():100148. PubMed ID: 36466363
[TBL] [Abstract][Full Text] [Related]
13. Cytokine/Chemokine Expression Is Closely Associated Disease Severity of Human Adenovirus Infections in Immunocompetent Adults and Predicts Disease Progression.
Li J; Wei J; Xu Z; Jiang C; Li M; Chen J; Li Y; Yang M; Gu Y; Wang F; Shu Y; Yang Y; Sun L; Liu Y
Front Immunol; 2021; 12():691879. PubMed ID: 34163488
[TBL] [Abstract][Full Text] [Related]
14. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm.
Torabi-Rahvar M; Rezaei N
Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863
[TBL] [Abstract][Full Text] [Related]
15. The Role of MSC Therapy in Attenuating the Damaging Effects of the Cytokine Storm Induced by COVID-19 on the Heart and Cardiovascular System.
Ellison-Hughes GM; Colley L; O'Brien KA; Roberts KA; Agbaedeng TA; Ross MD
Front Cardiovasc Med; 2020; 7():602183. PubMed ID: 33363221
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody therapy in COVID-19.
Conti P; Pregliasco FE; Calvisi V; Caraffa Al; Gallenga CE; Kritas SK; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(2):423-427. PubMed ID: 33904269
[TBL] [Abstract][Full Text] [Related]
17. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
Gu T; Zhao S; Jin G; Song M; Zhi Y; Zhao R; Ma F; Zheng Y; Wang K; Liu H; Xin M; Han W; Li X; Dong CD; Liu K; Dong Z
Front Immunol; 2020; 11():621441. PubMed ID: 33584719
[TBL] [Abstract][Full Text] [Related]
18. Cytokine storm modulation in COVID-19: a proposed role for vitamin D and DPP-4 inhibitor combination therapy (VIDPP-4i).
Pinheiro MM; Fabbri A; Infante M
Immunotherapy; 2021 Jun; 13(9):753-765. PubMed ID: 33906375
[TBL] [Abstract][Full Text] [Related]
19. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm.
Rabiu Abubakar A; Ahmad R; Rowaiye AB; Rahman S; Iskandar K; Dutta S; Oli AN; Dhingra S; Tor MA; Etando A; Kumar S; Irfan M; Gowere M; Chowdhury K; Akter F; Jahan D; Schellack N; Haque M
Life (Basel); 2022 Mar; 12(4):. PubMed ID: 35454970
[TBL] [Abstract][Full Text] [Related]
20. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
Kumar V
Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
